Virginia's daily average of new COVID-19 cases hit a record high for the third straight day Monday, as hospitalizations for treatment of the virus set another new record as well. 

The Virginia Department of Health reported 3,771 new cases of coronavirus on Monday, following 5,010 on Sunday, the third day since the pandemic began that the state has reported more than 5,000 new cases.

The state's seven-day average of new cases now stands at a record high of 4,480.1.  The average is up 24% in the  past week and 78.6% in the past month. 

Virginia's Eastern (996), Central (743.9) and Northwest (815.9) health regions all also set new record highs for seven-day averages Monday, with the Eastern region reporting its two highest days of new cases Sunday and Monday. 

In Northern Virginia, the seven-day average of new cases stands at 1,054.9, just below the record of 1,124.4, set Dec. 12.  The health department reported 711 new cases in the region on Monday, following 1,180 on Sunday.

The Virginia Hospital and Healthcare Association reported Monday that a record 2,765 patients are hospitalized statewide for treatment of COVID-19, with a record 563 of those in intensive-care units.  Hospitalizations are up 49% in the past month.

In Northern Virginia, 584 patients are hospitalized, still below the region's high of 808 on April 30. 

The health department reported 15 new deaths related to COVID-19 in the past two days: seven Sunday and eight Monday.  Death reports tend to be significantly higher during the week, however.  In Northern Virginia, three new deaths were reported over the  two-day period: two in Fairfax County and one in Arlington County.

Northern Virginia data by locality (Jan. 4, 2021)

SOURCE: Virginia Department of Health

Locality Cases Hospitalizations Deaths
Alexandria 7,538 442 88
Arlington 9,290 667 182
Fairfax 46,096 2,988 687
Fairfax City 311 26 10
Falls Church 188 18 6
Loudoun 14,569 654 161
Manassas 2,991 147 29
Manassas Park 953 65 8
Prince William 26,664 1,228 262
Totals 108,600 6,235 1,433
County/City Cases Hospitalizations Deaths
Fredericksburg 1,077 67 11
Spotsylvania 5,001 213 68
Stafford 5,481 231 25
Fauquier 2,555 94 28
Culpeper 3,094 135 23

Meanwhile, test positivity rates continue to rise across the region and statewide. In Northern Virginia, only Arlington's rate is below 10%. Experts believe that test positivity rates above 10% generally mean that not all cases of the virus are being identified. 

Seven-day average test positivity rate by health district (Jan. 4, 2021)

SOURCE: Virginia Department of Health

Health District Peak Low Current Trend
Alexandria 40.1% / April 23 3.2% / Oct. 18 10.9% Up
Arlington 42.8% / April 20 2.4% / June 26 9.9% Stable
Fairfax 38.6% / April 22 3.3% / Oct. 16 14.5% Up
Loudoun 27.9% / April 28 4.0% / Sept. 30 & Oct. 3 16.6% Up
Prince William 36.7% / April 18 5.4% / Oct. 20 20.8% Up
Rappahannock 17.2% / May 8 3.5% / July 3 17.6% Up
Statewide 20.6% / April 22 4.5% / Sept. 30, Oct. 1,2,12 & 13 15.8% Up

The health department's data show that as of Saturday, at least 87,618 Virginians had received the first doses of either the Pfizer or Moderna vaccine, both of which require two doses to be fully effective.  That's less than 25% of the 404,675 doses of the vaccines the state has received. 


New Cases/Deaths

  • Northern Virginia: 711 new cases, 3 new deaths Sunday and Monday combined. 

  • Statewide: 3,771 new cases, 8 new deaths.

  • Statewide Testing: 17,997 PCR diagnostic test results.     

Overall Total

  • Northern Virginia: 108,600 cases, 1,433 deaths  

  • Statewide: 367,536 cases, 5,132 deaths

  • Statewide Testing: 4.38 million PCR diagnostic tests (5.26 million when including antibody and antigen tests)  

  • Multisystem Inflammatory Syndrome in Children (MIS-C) cases: 13 

*Provided by Virginia Department of Health. The health department's COVID-19 data is updated each morning by 10 a.m. and includes reports by local health agencies before 5 p.m. the previous day.

Statewide Hospital and Nursing Home Data

  • Hospitalizations: 2,765 (up from 2,708 the previous day)

  • Peak Hospitalizations: 2,765 reached Jan. 4

  • Patients in ICU: 563 (up from 557 the previous day and the most ever)

  • Patients Discharged: 31,561 total

  • Nursing Home Patients: 1,870 as of Saturday (no reports on Sunday or Monday) 

*Provided by Virginia Hospital and Healthcare Association

For updated national and international COVID-19 data, visit the Johns Hopkins University coronavirus dashboard

See more headlines at Email tips to

(5) comments


How sad that they've had over 6 months to prepare for the vaccine, and yet they can't devote the resources to get people inoculated quickly. Perhaps its more profitable to have you admitted as a patient rather than provide immunity?

John Dutko

Well...This is a herculean task on many fronts with multiple moving parts.

Brush aside the fact that the necessary steps to ensure a swift and efficient method for dispersing the vaccine was half-assed.

It was identified that there was a needle shortage in early May ( ) And the whistleblower who made a Congressional testimony was fired for identifying it (Rick Bright). An order was made to boost the supply of needles (

Next part is the actual vaccine itself. It is miraculous that 6 version of the vaccine were produced so fast in different areas of the world with such high success rates. But, the actual vaccine needs to be synthesized as well as all of the other factors that go into a completed product:

"Whatever happens with syringes, other equipment also needs to be lined up to pull off vaccination drives without any delays. Makers of pharmaceutical glass are filling orders for billions of vaccine vials, and developing new, stronger kinds of glass. The likelihood of a vial shortage depends on how many governments and hospitals globally opt for the Pfizer or Moderna mRNA vaccines, which come packaged in 5-dose vials, versus the AstraZeneca or other non-mRNA vaccines that can be packaged in higher-dose vials.

The mRNA vaccines also make use of lipid nanoparticles to encase and protect strands of the genetic material; these have to be produced in a lab and were most likely the missing supply that caused Pfizer to announce on Dec. 3 that it would deliver 50 million fewer vaccines than anticipated this year.

“If the whole world says ‘We’re going to get Pfizer and Moderna mRNA vaccine,’ then we are facing a serious shortage of lipids,” Yadav said."

MEANWHILE, you have a portion of the population who flaunt the existence of the virus, lending itself to higher cases, leading to higher hospitalizations, thereby reducing the ICU capacity---which in turn leads to higher deaths as people cannot get the treatment they need. That is the reason for "flattening the curve".

Look at Los Angeles.

As to your last part, no.

The health insurance companies do not want you to die. They want you to pay a premium and not use their services. If by chance you need an expensive procedure, they are well within their right to drop you from their plans. It's because they are a business, and profits come first. Which is why medicare for all should be implemented.

The smoking industry does not want you to die, because then they lose a customer.


Daily virus porn. I was eagerly awaiting. Ohh no, more “positive” tests, ahhhh. We’re all going to die! The average American these days is such an idiot, sad end to a once great society.

Fix Prince William

Shallow Hal! Ha ha! You're such a troll. Did you see one of our strong, conservative state representatives died of the virus? God rest his soul.

John Dutko

I would love to hear your take on what germ theory is.

Welcome to the discussion.

Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
Share with Us. We'd love to hear eyewitness accounts, the history behind an article.